Until recently, Nikolay et al. indicated that LPA3 was higher expressed in human breast cancers, and most interesting LPA3 overexpression was associated with absence of ER and PR [30], which suggests a function of LPA3 in HR− carcinomas. Here, LPAR3 is linked to breast carcinoma.